---
title: å—å•¡
description: 
published: true
date: 2026-01-30T09:39:31.298Z
tags: freeodwikiæ˜¯ä¸€ä¸ªå¼€æºé¡¹ç›®ï¼Œæä¾›æœ‰å…³odã€overdoseã€è¯ç‰©æ»¥ç”¨ã€è¯ç‰©è¿‡é‡ã€å¸æ¯’ã€æ¯’å“ã€ç¦æ¯’ç­‰è¯é¢˜çš„çŸ¥è¯†ã€‚
editor: markdown
dateCreated: 2026-01-30T05:57:49.421Z
---

# å—å•¡ï¼ˆMorphineï¼‰
>
> é™¢é•¿å’Œå—å•¡ä¸¢äº†ï¼Œå…ˆæ‰¾å—å•¡
>



å—å•¡
===
[â—€è¿”å›](/è¯ç‰©/home.md)
| | |
|--|-- |
|![Skull and crossbones darktextred2.png](/æ–‡ä»¶/Skull_and_crossbones_darktextred2.png)|**å½“[é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)è¯ç‰©ä¸å…¶å®ƒ[æŠ‘åˆ¶å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)ï¼ˆå¦‚[è‹¯äºŒæ°®å“ç±»è¯ç‰©](/è‹¯äºŒæ°®å“ç±»ç‰©è´¨.md)ã€[å·´æ¯”å¦¥ç±»](/è¯ç‰©/å·´æ¯”å¦¥ç±».md)ã€[åŠ å·´å–·ä¸ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/åŠ å·´å–·ä¸ç±».md)ã€[å™»å©äºŒæ°®å“ç±»](/è¯ç‰©/å™»å©äºŒæ°®å“ç±».md)ã€[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)æˆ–å…¶å®ƒ[GABAèƒ½ç‰©è´¨](/å—ä½“è›‹ç™½.md)ï¼‰[è¯ç‰©è”ç”¨](/è¯ç‰©æ¦‚è¿°.md)æ—¶ï¼Œå¯èƒ½ä¼šå¯¼è‡´è‡´å‘½çš„[è¯ç‰©è¿‡é‡](/è¯ç‰©è¿‡é‡çš„æ•‘åŠ©æ–¹æ³•.md)ã€‚[\[1\]](#cite_note-tripsit-1)**

å¼ºçƒˆå»ºè®®ä¸è¦æ··åˆä½¿ç”¨è¿™äº›ç‰©è´¨ï¼Œç‰¹åˆ«æ˜¯åœ¨[ä¸­ç­‰](/è¯ç‰©æ¦‚è¿°.md)åˆ°[ä¸¥é‡](/è¯ç‰©æ¦‚è¿°.md)å‰‚é‡ä¸‹ã€‚

| **æ‘˜è¦ï¼šå—å•¡ (Morphine)** |
| --- |

| | |
| --- | --- |
| [![Morphine.png](/æ–‡ä»¶/Morphine.png)](/æ–‡ä»¶/Morphine.png) | |
| **åŒ–å­¦å‘½å** | |
| ä¿—å | *Morphine, MS-Contin, Oramorph, Zomorph, Sevredol, Duramorph* |
| [å–ä»£åç§°](/è¯ç‰©æ¦‚è¿°.md) | *Morphine* |
| ç³»ç»Ÿå‘½åæ³• | *(5Î±,6Î±)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol* |
| **åˆ†ç±»** | |
| ç²¾ç¥æ´»æ€§åˆ†ç±» | *[é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)* |
| åŒ–å­¦åˆ†ç±» | *[å—å•¡å–ƒ](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å—å•¡å–ƒ.md)* |
| **[ç»™è¯é€”å¾„](/è¯ç‰©æ¦‚è¿°.md)** | |
| **è­¦å‘Šï¼š** ç”±äºä¸ªä½“ä½“é‡ã€è€å—æ€§ã€ä»£è°¢å’Œä¸ªäººæ•æ„Ÿåº¦çš„å·®å¼‚ï¼Œè¯·åŠ¡å¿…ä»ä½å‰‚é‡å¼€å§‹ã€‚[å¦è§ä¼¤å®³å‡å°‘æªæ–½éƒ¨åˆ†](/è¯ç‰©åº”å¯¹æªæ–½/home.md)ã€‚ | |

| [å£æœ](/è¯ç‰©æ¦‚è¿°.md) | |
| --- | --- |
| **[å‰‚é‡](/è¯ç‰©æ¦‚è¿°.md)** | |
| ç”Ÿç‰©åˆ©ç”¨åº¦ | 35% - 40% |
| [é˜ˆå€¼](/è¯ç‰©æ¦‚è¿°.md) | < 10 mg |
| [è½»å¾®](/è¯ç‰©æ¦‚è¿°.md) | 10 - 15 mg |
| [ä¸­ç­‰](/è¯ç‰©æ¦‚è¿°.md) | 15 - 20 mg |
| [å¼ºçƒˆ](/è¯ç‰©æ¦‚è¿°.md) | 20 - 30 mg |
| [ä¸¥é‡](/è¯ç‰©æ¦‚è¿°.md) | 30 mg + |
| **æŒç»­æ—¶é—´** | |
| [æ€»æ—¶é•¿](/è¯ç‰©æ¦‚è¿°.md) | 4 - 6 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](/è¯ç‰©æ¦‚è¿°.md) | 10 - 30 åˆ†é’Ÿ |
| [è¯æ•ˆä¸Šå‡](/è¯ç‰©æ¦‚è¿°.md) | 20 - 40 åˆ†é’Ÿ |
| [è¯æ•ˆè¾¾å³°](/è¯ç‰©æ¦‚è¿°.md) | 2 - 3 å°æ—¶ |
| [è¯æ•ˆè¤ªå»](/è¯ç‰©æ¦‚è¿°.md) | 1 - 2 å°æ—¶ |
| [è¯æ•ˆæ®‹ä½™](/è¯ç‰©æ¦‚è¿°.md) | 12 å°æ—¶ |

| [é™è„‰æ³¨å°„](/è¯ç‰©æ¦‚è¿°.md) | |
| --- | --- |
| **[å‰‚é‡](/è¯ç‰©æ¦‚è¿°.md)** | |
| ç”Ÿç‰©åˆ©ç”¨åº¦ | 100% |
| [é˜ˆå€¼](/è¯ç‰©æ¦‚è¿°.md) | < 3.33 mg |
| [è½»å¾®](/è¯ç‰©æ¦‚è¿°.md) | 3.33 - 5 mg |
| [ä¸­ç­‰](/è¯ç‰©æ¦‚è¿°.md) | 5 - 7.5 mg |
| [å¼ºçƒˆ](/è¯ç‰©æ¦‚è¿°.md) | 7.5 - 10 mg |
| [ä¸¥é‡](/è¯ç‰©æ¦‚è¿°.md) | 10 mg + [\[2\]](#cite_note-Medsafe-2) [\[3\]](#cite_note-FDA-3) [\[4\]](#cite_note-South_Australian_Neonatal_Medication_Guidelines-4) [\[5\]](#cite_note-Pfizer-5) |
| **æŒç»­æ—¶é—´** | |
| [æ€»æ—¶é•¿](/è¯ç‰©æ¦‚è¿°.md) | 4 - 5 å°æ—¶ |
| [è¯æ•ˆå‘ä½œ](/è¯ç‰©æ¦‚è¿°.md) | 0 - 30 ç§’ |
| [è¯æ•ˆä¸Šå‡](/è¯ç‰©æ¦‚è¿°.md) | 2 - 5 åˆ†é’Ÿ |
| [è¯æ•ˆè¾¾å³°](/è¯ç‰©æ¦‚è¿°.md) | 1.5 - 2.5 å°æ—¶ |
| [è¯æ•ˆè¤ªå»](/è¯ç‰©æ¦‚è¿°.md) | 60 - 90 åˆ†é’Ÿ |
| [è¯æ•ˆæ®‹ä½™](/è¯ç‰©æ¦‚è¿°.md) | 12 å°æ—¶ |

| **[è¯ç‰©è”ç”¨](#Dangerous_interactions)** | |
| --- | --- |
| âš ï¸ æ…ç”¨ | [å…´å¥‹å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å…´å¥‹å‰‚.md) |
| âš ï¸ æ…ç”¨ | [MAOIs](/é…¶æŠ‘åˆ¶å‰‚.md) |
| âš ï¸ æ…ç”¨ | [æ°§åŒ–äºšæ°®](/è¯ç‰©/æ°§åŒ–äºšæ°®.md) |
| âš ï¸ æ…ç”¨ | [PCP](/è¯ç‰©/PCP.md) |
| ğŸ’” å±é™© | [é…’ç²¾](/è¯ç‰©/é…’ç²¾.md) |
| ğŸ’” å±é™© | [è‹¯äºŒæ°®å“ç±»è¯ç‰©](/è‹¯äºŒæ°®å“ç±»ç‰©è´¨.md) |
| ğŸ’” å±é™© | [å³ç¾æ²™èŠ¬](/è¯ç‰©/å³ç¾æ²™èŠ¬.md) |
| ğŸ’” å±é™© | [GHB](/è¯ç‰©/GHB.md) |
| ğŸ’” å±é™© | [GBL](/è¯ç‰©/GBL.md) |
| ğŸ’” å±é™© | [æ°¯èƒºé…®](/è¯ç‰©/æ°¯èƒºé…®.md) |
| ğŸ’” å±é™© | [MXE](/è¯ç‰©/MXE.md) |
| ğŸ’” å±é™© | [æ›²é©¬å¤š](/è¯ç‰©/æ›²é©¬å¤š.md) |
| ğŸ’” å±é™© | [è‘¡è„æŸš](/è¯ç‰©/è‘¡è„æŸš.md) |
| **å…è´£å£°æ˜ï¼š** æœ¬ç«™çš„[å‰‚é‡](/è¯ç‰©æ¦‚è¿°.md)ä¿¡æ¯æ¥æºäºç”¨æˆ·æŠ¥å‘Šå’Œæ•™è‚²èµ„æºï¼Œä»…ä¾›å‚è€ƒã€‚è¿™ä¸æ„æˆåŒ»ç–—å»ºè®®ï¼Œåº”é€šè¿‡å…¶ä»–æ¥æºæ ¸å®å‡†ç¡®æ€§ã€‚ | |

**å—å•¡**ï¼ˆMorphineï¼‰æ˜¯ä¸€ç§[å¤©ç„¶å­˜åœ¨](/ç”Ÿå‘½ç§‘å­¦çº²è¦.md)çš„[å—å•¡å–ƒ](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å—å•¡å–ƒ.md)ç±»[é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)ç‰©è´¨ã€‚å®ƒæ˜¯å‘ç°äº[é¸¦ç‰‡](/è¯ç‰©/é¸¦ç‰‡.md)ä¸­çš„å¤©ç„¶æ¤ç‰©[ç”Ÿç‰©ç¢±](/ç”Ÿå‘½ç§‘å­¦çº²è¦.md)ä¹‹ä¸€ï¼Œé€šå¸¸ä¸[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)å¹¶å­˜ï¼Œæå–è‡ª*[ç½‚ç²Ÿ](/è¯ç‰©/ç½‚ç²Ÿ.md)*ï¼ˆ*Papaver somniferum*ï¼‰ã€‚[\[6\]](#cite_note-6) æ­¤å¤–ï¼Œå®ƒè¢«è®¤ä¸ºæ˜¯é˜¿ç‰‡ç±»è¯ç‰©çš„åŸå‹ï¼ˆå³ä¸å…¶ä»–è¯ç‰©è¿›è¡Œæ¯”è¾ƒçš„æ ‡å‡†ï¼‰ï¼Œä¹Ÿæ˜¯[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)ã€[äºŒä¹™é…°å—å•¡](/è¯ç‰©/æµ·æ´›å› .md)ï¼ˆæµ·æ´›å› ï¼‰å’Œ[æ°¢å¯é…®](/è¯ç‰©/æ°¢å¯é…®.md)ç­‰è¡ç”Ÿç‰©çš„åŸºç¡€ã€‚

1806å¹´ï¼Œå¾·å›½è¯å‰‚å¸ˆåŠ©ç† Friedrich SertÃ¼rner é¦–æ¬¡ä»[é¸¦ç‰‡](/è¯ç‰©/é¸¦ç‰‡.md)ä¸­åˆ†ç¦»å‡ºå—å•¡ã€‚[\[7\]](#cite_note-Sertiirner1806-7)

å…¶[ä¸»è§‚æ•ˆåº”](/è¯æ•ˆ/home.md)åŒ…æ‹¬[é•‡é™](/è¯æ•ˆ/é•‡é™.md)ã€[é•‡ç—›](/è¯æ•ˆ/é•‡ç—›.md)ã€[å’³å—½æŠ‘åˆ¶](/è¯æ•ˆ/å’³å—½æŠ‘åˆ¶.md)å’Œ[æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)ã€‚å—å•¡å…·æœ‰æ½œåœ¨çš„ä¸¥é‡å‰¯ä½œç”¨ï¼Œå¦‚[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)å’Œ[è¡€å‹é™ä½](/è¯æ•ˆ/è¡€å‹é™ä½.md)ï¼Œå½“ä¸å…¶å®ƒ[æŠ‘åˆ¶å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)æ··åˆä½¿ç”¨æ—¶å¯èƒ½ä¼šè‡´å‘½ã€‚å—å•¡çš„å…¶ä»–å‰¯ä½œç”¨åŒ…æ‹¬å—œç¡ã€å‘•åå’Œä¾¿ç§˜ã€‚

[![](https://upload.wikimedia.org/wikipedia/commons/thumb/9/9d/Slaapbol_R0017600.JPG/250px-Slaapbol_R0017600.JPG)](/æ–‡ä»¶/Slaapbol_R0017600.JPG)

[](/æ–‡ä»¶/Slaapbol_R0017600.JPG "æ”¾å¤§")

å—å•¡çš„ä¸»è¦æ¥æºæ˜¯ä»ç½‚ç²Ÿçš„ç½‚ç²Ÿç§†ä¸­åˆ†ç¦»å‡ºæ¥çš„ã€‚

å—å•¡å¯ä»¥é€šè¿‡å£æœã€è‚Œè‚‰æ³¨å°„ã€çš®ä¸‹æ³¨å°„ã€é™è„‰æ³¨å°„ã€é˜å†…æ³¨å°„æˆ–ç›´è‚ ç»™è¯ã€‚é™è„‰æ³¨å°„æ—¶çº¦20åˆ†é’Ÿè¾¾åˆ°æœ€å¤§æ•ˆæœï¼Œå£æœæ—¶çº¦60åˆ†é’Ÿï¼Œè¯æ•ˆæŒç»­æ—¶é—´åœ¨3åˆ°7å°æ—¶ä¹‹é—´ã€‚[\[8\]](#cite_note-8)[\[9\]](#cite_note-9) åŒæ—¶ä¹Ÿå­˜åœ¨é•¿æ•ˆåˆ¶å‰‚ï¼Œå¦‚ Kadianï¼Œèƒ½å¤Ÿäº§ç”Ÿé•¿è¾¾24å°æ—¶çš„ä¸´åºŠæ˜¾è‘—æ•ˆæœã€‚[\[10\]](#cite_note-10)[\[11\]](#cite_note-11)

å—å•¡è¢«å¹¿æ³›è®¤ä¸ºå…·æœ‰æ˜¾è‘—çš„æ»¥ç”¨æ½œåŠ›ã€‚é™¤äº†å•æ¬¡ä½¿ç”¨å¯¼è‡´è‡´å‘½è¿‡é‡çš„é£é™©å¤–ï¼Œé•¿æœŸä½¿ç”¨å—å•¡è¿˜ä¸ä¸æ–­å‡çº§çš„è€å—æ€§ã€ç”Ÿç†å’Œå¿ƒç†ä¾èµ–æœ‰å…³ï¼Œè¿™å¯èƒ½ç»™ä½¿ç”¨è€…å¸¦æ¥é‡å¤§ä¼¤å®³ã€‚å¦‚æœä½¿ç”¨æ­¤ç‰©è´¨ï¼Œå¼ºçƒˆå»ºè®®é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/è¯ç‰©åº”å¯¹æªæ–½/home.md)ã€‚

ç›®å½•
--------

* [1 å†å²ä¸æ–‡åŒ–](#History_and_culture)
* [2 åŒ–å­¦](#Chemistry)
* [3 è¯ç†å­¦](#Pharmacology)
    + [3.1 å—å•¡çš„ç»“åˆäº²å’ŒåŠ› (Ki)\[31\]](#Binding_affinities_of_morphine_.28Ki.29.5B31.5D)
* [4 é¼»å¸å¢å¼º](#Intranasal_potentiation)
* [5 ä¸»è§‚æ•ˆåº”](#Subjective_effects)
    + [5.1 **èº¯ä½“æ•ˆåº”**](#Physical_effects)
    + [5.2 **è®¤çŸ¥æ•ˆåº”**](#Cognitive_effects)
    + [5.3 **è§†è§‰æ•ˆåº”**](#Visual_effects)
        - [5.3.1 æŠ‘åˆ¶](#Suppressions)
        - [5.3.2 å¹»è§‰çŠ¶æ€](#Hallucinatory_States)
    + [5.4 ä½“éªŒæŠ¥å‘Š](#Experience_reports)
* [6 æ¯’æ€§ä¸å±å®³æ½œåŠ›](#Toxicity_and_harm_potential)
    + [6.1 ä¾èµ–æ€§ä¸æ»¥ç”¨æ½œåŠ›](#Dependence_and_abuse_potential)
    + [6.2 å±é™©çš„ç›¸äº’ä½œç”¨](#Dangerous_interactions)
* [7 æ³•å¾‹åœ°ä½](#Legal_status)
* [8 å¦è§](#See_also)
* [9 å¤–éƒ¨é“¾æ¥](#External_links)
* [10 æ–‡çŒ®](#Literature)
* [11 å‚è€ƒæ–‡çŒ®](#References)

å†å²ä¸æ–‡åŒ–
-------------------

å—å•¡äº1806å¹´é¦–æ¬¡ç”±å¾·å›½è¯å‰‚å¸ˆåŠ©ç† Friedrich SertÃ¼rner åˆ†ç¦»å‡ºæ¥ã€‚[\[7\]](#cite_note-Sertiirner1806-7) åœ¨ SertÃ¼rner çš„50å¤šæ¬¡å®éªŒä¸­ï¼Œä»–ç›¸ä¿¡è‡ªå·±åˆ†ç¦»å‡ºäº†[é¸¦ç‰‡](/è¯ç‰©/é¸¦ç‰‡.md)ä¸­çš„ä¸»è¦æ´»æ€§æˆåˆ†ã€‚è¿™é€šå¸¸è¢«è®¤ä¸ºæ˜¯é¦–æ¬¡ä»æ¤ç‰©ä¸­åˆ†ç¦»å‡ºæ´»æ€§æˆåˆ†ã€‚[\[12\]](#cite_note-12)[\[13\]](#cite_note-13) è¿™ç§æ´»æ€§æˆåˆ†è¢«å‘ç°æ¯”[é¸¦ç‰‡](/è¯ç‰©/é¸¦ç‰‡.md)å¼º10å€ã€‚SertÃ¼rner æœ€åˆå°†è¿™ç§ç‰©è´¨å‘½åä¸º *morphium*ï¼Œä»¥å¸Œè…Šæ¢¦ç¥ Morpheus å‘½åï¼Œå› ä¸ºå®ƒæœ‰è‡´çœ çš„å€¾å‘ã€‚[\[14\]](#cite_note-Mosher2013-14)[\[15\]](#cite_note-15) é»˜å…‹ï¼ˆMerckï¼‰å…¬å¸äº1827å¹´å¼€å§‹å•†ä¸šåŒ–é”€å”®ã€‚[\[16\]](#cite_note-Courtwright2009-16) ç›´åˆ°1831å¹´ SertÃ¼rner å› å…¶è´¡çŒ®è·å¾—ç›¸å½“äºè¯ºè´å°”å¥–çš„æ³•å›½å¥–é¡¹åï¼Œå—å•¡çš„ä¸´åºŠæ„ä¹‰æ‰è¢«æ›´å¹¿æ³›çš„åŒ»å­¦ç•Œæ‰€è®¤å¯ã€‚åæ¥ä»[é¸¦ç‰‡](/è¯ç‰©/é¸¦ç‰‡.md)æ¤ç‰©ä¸­é‰´å®šå‡ºäº†å…¶ä»–ç”Ÿç‰©ç¢±ï¼Œè¿™ä¸‰åç§ç”Ÿç‰©ç¢±ä¸­çš„ä¸€ç§åæ¥æˆä¸ºäº†[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)ã€‚[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)æºè‡ªå¤å¸Œè…Šè¯­ ÎºÏÎ´ÎµÎ¹Î±ï¼Œæ„ä¸ºåƒç½‚ç²Ÿå¤´ä¸€æ ·çš„æ¯å­ã€‚[\[17\]](#cite_note-17) éšç€ Alexander Wood åšå£«åœ¨1853å¹´å‘æ˜çš®ä¸‹æ³¨å°„å™¨ï¼Œå—å•¡çš„ä½¿ç”¨å¾—åˆ°äº†æ¨å¹¿ã€‚[\[16\]](#cite_note-Courtwright2009-16)[\[14\]](#cite_note-Mosher2013-14) ç„¶è€Œï¼Œç›´åˆ°1861å¹´çš„ç¾å›½å†…æˆ˜ã€1866å¹´çš„æ™®å¥¥æˆ˜äº‰å’Œ1870å¹´çš„æ™®æ³•æˆ˜äº‰ï¼Œå—å•¡æ‰ä½œä¸ºå†›äº‹åŒ»å­¦çš„ä¸€éƒ¨åˆ†å¾—åˆ°å¹¿æ³›ä½¿ç”¨ã€‚åœ¨è¿™äº›å†›äº‹å†²çªä¹‹åï¼Œå—å•¡æˆç˜¾è·å¾—äº†â€œå£«å…µç—…â€æˆ–â€œå†›é˜Ÿç—…â€çš„åå£°ã€‚éšç€å—å•¡çš„æˆç˜¾æ€§å’Œä¹ æƒ¯å½¢æˆç‰¹æ€§ä¸ºäººæ‰€çŸ¥ï¼ŒåŒ»ç–—æœºæ„å¼€å§‹å¯»æ‰¾ä¸€ç§æˆç˜¾æ€§è¾ƒä½çš„å—å•¡æ›¿ä»£å“ã€‚è¿™ä»¥äºŒä¹™é…°å—å•¡çš„å½¢å¼å‡ºç°ï¼Œåæ¥ä»¥[æµ·æ´›å› ](/è¯ç‰©/æµ·æ´›å› .md)çš„åç§°ä¸Šå¸‚ã€‚è™½ç„¶äººä»¬åæ¥äº†è§£åˆ°[æµ·æ´›å› ](/è¯ç‰©/æµ·æ´›å› .md)çš„æˆç˜¾æ€§å¹¶ä¸æ¯”[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)ä½ï¼Œäº‹å®æ°æ°ç›¸åã€‚å—å•¡çš„ç¬¬ä¸€ä¸ªåŒ–å­¦ç»“æ„ç”± Robinson åŠå…¶åŒäº‹äº1923å¹´æå‡ºï¼Œå¹¶åœ¨1927å¹´å¾—åˆ°ç¡®è®¤ã€‚[\[18\]](#cite_note-18)[\[19\]](#cite_note-19)[\[20\]](#cite_note-20) å—å•¡çš„å…¨åŒ–å­¦åˆæˆäº1952å¹´ç”± Gates å’Œ Tschudi å®Œæˆã€‚[\[21\]](#cite_note-21)

å—å•¡çš„ä¸»è¦æ¥æºæ˜¯ä»[ç½‚ç²Ÿ](/è¯ç‰©/ç½‚ç²Ÿ.md)ï¼ˆ*Papaver somniferum*ï¼‰çš„ç½‚ç²Ÿç§†ä¸­åˆ†ç¦»å‡ºæ¥çš„ã€‚[\[22\]](#cite_note-22) 2013å¹´ä¼°è®¡ç”Ÿäº§äº†523,000å…¬æ–¤å—å•¡ã€‚[\[23\]](#cite_note-:1-23) å…¶ä¸­çº¦45,000å…¬æ–¤ç›´æ¥ç”¨äºæ­¢ç—›ï¼Œè¿™æ¯”è¿‡å»äºŒåå¹´å¢åŠ äº†å››å€ã€‚[\[23\]](#cite_note-:1-23) è¿™äº›ç”¨é€”å¤§å¤šå‘ç”Ÿåœ¨å‘è¾¾å›½å®¶ã€‚[\[24\]](#cite_note-24) çº¦70%çš„å—å•¡ç”¨äºåˆ¶é€ å…¶ä»–[é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)è¯ç‰©ï¼Œå¦‚[æ°¢å—å•¡é…®](/è¯ç‰©/æ°¢å—å•¡é…®.md)ã€[ç¾Ÿè€ƒé…®](/è¯ç‰©/ç¾Ÿè€ƒé…®.md)å’Œ[æµ·æ´›å› ](/è¯ç‰©/æµ·æ´›å› .md)ã€‚[\[25\]](#cite_note-25)[\[26\]](#cite_note-Busse2008-26)[\[27\]](#cite_note-27)

åŒ–å­¦
---------

å—å•¡æ˜¯ä¸€ç§è‹„åŸºå¼‚å–¹å•‰[ç”Ÿç‰©ç¢±](/ç”Ÿå‘½ç§‘å­¦çº²è¦.md)ï¼Œå±äº[å—å•¡å–ƒ](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/å—å•¡å–ƒ.md)ç±»é˜¿ç‰‡ã€‚å—å•¡å’Œè¯¥ç±»åˆ«çš„å…¶ä»–åˆ†å­åŒ…å«ä¸€ä¸ªç”±ä¸‰ä¸ªè‹¯ç¯ä»¥ä¹‹å­—å½¢ç¨ åˆè€Œæˆçš„å¤šç¯æ ¸å¿ƒï¼Œç§°ä¸ºè²ã€‚ç¬¬å››ä¸ªå«æ°®ç¯åœ¨ R9 å’Œ R13 å¤„ä¸è²ç¨ åˆï¼Œæ°®åŸå­ä½äºç»„åˆç»“æ„çš„ R17 å¤„ã€‚è¿™ç§ç»“æ„è¢«ç§°ä¸ºå—å•¡å–ƒã€‚

å—å•¡ï¼ˆä»¥åŠå…¶ä»–å—å•¡å–ƒç±»ï¼‰åœ¨å…¶ä¸¤ä¸ªç¯ä¹‹é—´åŒ…å«ä¸€ä¸ªé†šæ¡¥ï¼Œé€šè¿‡ä¸€ä¸ªæ°§åŸºå›¢è¿æ¥ R4 å’Œ R5ã€‚å®ƒåŒ…å«ä¸¤ä¸ªç¾ŸåŸºï¼ˆOH-ï¼‰ï¼Œåˆ†åˆ«ç»“åˆåœ¨ R6 å’Œ R3ï¼Œä»¥åŠä½äº R17 æ°®åŸå­ä¸Šçš„ä¸€ä¸ªç”²åŸºã€‚

å—å•¡æ˜¯è®¸å¤šå—å•¡å–ƒç±»è¯ç‰©çš„å‰ä½“ï¼Œå®ƒé€šè¿‡ R3 ç¾ŸåŸºçš„ç”²åŸºåŒ–ç”¨äºåˆæˆ[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)ï¼Œé€šè¿‡ä¹™é…°åŒ–ç”¨äºåˆæˆæµ·æ´›å› ã€‚å…¶ä»–å¯†åˆ‡ç›¸å…³çš„é˜¿ç‰‡ç±»è¯ç‰©åŒ…æ‹¬[æ°¢å¯é…®](/è¯ç‰©/æ°¢å¯é…®.md)ã€[ç¾Ÿè€ƒé…®](/è¯ç‰©/ç¾Ÿè€ƒé…®.md)å’Œ[äºŒæ°¢å¯å¾…å› ](/è¯ç‰©/äºŒæ°¢å¯å¾…å› .md)ã€‚å—å•¡çš„åŒ–å­¦ç»“æ„æ˜¯æ•°ç™¾ç§å…·æœ‰å¹¿æ³›æ•ˆåº”çš„é˜¿ç‰‡ç±»è¡ç”Ÿç‰©çš„åŸºç¡€ã€‚

è¯ç†å­¦
------------

å—å•¡é€šè¿‡ç»“åˆå¹¶æ¿€æ´»ä¸‰ç§å·²çŸ¥çš„é˜¿ç‰‡å—ä½“æ¥å‘æŒ¥ä½œç”¨ï¼ŒåŒ…æ‹¬ï¼š[Îº-é˜¿ç‰‡](/å—ä½“è›‹ç™½.md) (KOP)ã€[Î¼-é˜¿ç‰‡](/å—ä½“è›‹ç™½.md) (MOP) å’Œ [Î´-é˜¿ç‰‡](/å—ä½“è›‹ç™½.md) (DOP) [å—ä½“](/å—ä½“è›‹ç™½.md)ï¼Œä½œä¸º[æ¿€åŠ¨å‰‚](/å—ä½“-é…ä½“ç»“åˆæ¨¡å‹.md)ã€‚è¿™æ˜¯å› ä¸ºé˜¿ç‰‡ç±»è¯ç‰©åœ¨åŠŸèƒ½ä¸Šæ¨¡ä»¿äº†äººä½“å¤©ç„¶çš„å†…å•¡è‚½ã€‚å†…å•¡è‚½è´Ÿè´£é•‡ç—›ï¼ˆå‡è½»ç–¼ç—›ï¼‰ã€ç¡æ„ä»¥åŠæ„‰æ‚¦å’Œäº«å—çš„æ„Ÿè§‰ã€‚å®ƒä»¬è¢«è®¤ä¸ºæ˜¯åœ¨ç–¼ç—›ã€å‰§çƒˆè¿åŠ¨ã€æ€§é«˜æ½®æˆ–å…´å¥‹æ—¶é‡Šæ”¾çš„ã€‚è¿™ç§å¯¹å¤©ç„¶å†…å•¡è‚½çš„æ¨¡ä»¿å¯¼è‡´äº†è¯ç‰©çš„[æ¬£å¿«](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)ã€[é•‡ç—›](/è¯æ•ˆ/é•‡ç—›.md)ï¼ˆç¼“è§£ç–¼ç—›ï¼‰å’Œ[æŠ—ç„¦è™‘](/è¯æ•ˆ/ç„¦è™‘æŠ‘åˆ¶.md)ä½œç”¨ã€‚

äººä½“ä¼šäº§ç”Ÿå°‘é‡å—å•¡ï¼Œå¹¶ä½œä¸ºå…ç–«è°ƒèŠ‚å‰‚å‘æŒ¥ä½œç”¨ã€‚å†…æºæ€§å—å•¡ä¼˜å…ˆç»“åˆ Î¼3 é˜¿ç‰‡å—ä½“ã€‚[\[28\]](#cite_note-28)

å—å•¡ä¸[æ°¢å—å•¡é…®](/è¯ç‰©/æ°¢å—å•¡é…®.md)å’Œ[ç¾Ÿå—å•¡é…®](/è¯ç‰©/ç¾Ÿå—å•¡é…®.md)ä¸€æ ·ï¼Œç»å†æå°‘çš„ CYP450 ä»£è°¢ï¼Œä¸»è¦ç”± UDP-è‘¡è„ç³–é†›é…¸è½¬ç§»é…¶ (UGTs) ä»£è°¢ï¼Œç‰¹åˆ«æ˜¯ UG2B7 åŒå·¥é…¶ã€‚[\[29\]](#cite_note-29) çº¦90%çš„å—å•¡è¢«è½¬åŒ–ä¸ºä»£è°¢äº§ç‰©ï¼Œä¸»è¦è½¬åŒ–ä¸ºè‘¡è„ç³–é†›é…¸ç»“åˆç‰©ï¼šå—å•¡-3-è‘¡è„ç³–é†›é…¸è‹· (M3G) (45-55%) å’Œå—å•¡-6-è‘¡è„ç³–é†›é…¸è‹· (M6G) (10-15%)ã€‚[\[30\]](#cite_note-:2-30) å…¶ä¸­ M3G å¯¹é˜¿ç‰‡å—ä½“çš„äº²å’ŒåŠ›ä½ï¼Œæ²¡æœ‰é•‡ç—›æ´»æ€§ã€‚M6G ç»“åˆçš„å—ä½“ä½ç‚¹ä¸å—å•¡ç›¸åŒï¼Œä½†å…·æœ‰æ›´é«˜çš„äº²å’ŒåŠ›å’Œæ›´å¼ºçš„æ•ˆåŠ›ã€‚[\[30\]](#cite_note-:2-30)

### å—å•¡çš„ç»“åˆäº²å’ŒåŠ› (Ki)[\[31\]](#cite_note-Schmidt2002-31)

Ki å€¼è¶Šä½ï¼Œè¡¨ç¤ºå¯¹å—ä½“çš„ç»“åˆäº²å’ŒåŠ›è¶Šé«˜ã€‚

* Mu (Î¼) é˜¿ç‰‡å—ä½“æ¿€åŠ¨å‰‚ - 4.9 nM
* Kappa (Îº) é˜¿ç‰‡å—ä½“æ¿€åŠ¨å‰‚ - 206 nM
* Delta (Î´) é˜¿ç‰‡å—ä½“æ¿€åŠ¨å‰‚ - 273 nM


é¼»å¸å¢å¼º
-----------------------

å°½ç®¡å—å•¡çš„é¼»å†…ç”Ÿç‰©åˆ©ç”¨åº¦é€šå¸¸è¾ƒä½ï¼ˆ~10-15%ï¼‰ï¼Œä½†ç ”ç©¶è¡¨æ˜ï¼Œå½“è¯ç‰©ä¸[å£³èšç³–](https://en.wikipedia.org/wiki/Chitosan)ï¼ˆä¸€ç§å¸¸è§çš„è†³é£Ÿè¡¥å……å‰‚ï¼‰ä»¥çº¦ 5:1 çš„é‡é‡æ¯”ï¼ˆå£³èšç³–:å—å•¡ï¼‰æ··åˆæ—¶ï¼Œç”Ÿç‰©åˆ©ç”¨åº¦å¯æé«˜è‡³çº¦ 60%[\[32\]](#cite_note-32)ï¼Œè¿™ä½¿å…¶ä¸ç›´è‚ ç»™è¯ç›¸å½“ã€‚è¿™ç§æ–¹æ³•æé«˜çš„ç”Ÿç‰©åˆ©ç”¨åº¦è¢«è®¤ä¸ºæ˜¯ç”±äºå£³èšç³–çš„ç”Ÿç‰©ç²˜é™„ç‰¹æ€§[\[33\]](#cite_note-33)ã€‚

ä¸»è§‚æ•ˆåº”
------------------

| ![Metacogghjgjvghnition.png](/æ–‡ä»¶/Metacogghjgjvghnition.png) | **ä¸»è§‚æ•ˆåº”éƒ¨åˆ†æ˜¯ä¸€ä¸ª[å°ä½œå“](/CONTRIBUTING.md)**ã€‚<br>*å› æ­¤ï¼Œå®ƒä»åœ¨å®Œå–„ä¸­ï¼Œå¯èƒ½åŒ…å«ä¸å®Œæ•´æˆ–é”™è¯¯çš„ä¿¡æ¯ã€‚*<br>*æ‚¨å¯ä»¥é€šè¿‡[æ‰©å±•æˆ–æ›´æ­£å®ƒ](https://psychonautwiki.org/w/index.php?title=Morphine&action=edit)æ¥æä¾›å¸®åŠ©ã€‚* |
| --- | --- |

***å…è´£å£°æ˜ï¼š** ä»¥ä¸‹åˆ—å‡ºçš„æ•ˆåº”å¼•ç”¨è‡ª[***ä¸»è§‚æ•ˆåº”ç´¢å¼•***](/è¯æ•ˆ/home.md) (**SEI**)ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºäºè½¶äº‹ç”¨æˆ·æŠ¥å‘Šå’Œ [PsychonautWiki](/å…³äºæœ¬ç«™/å…³äºFreeODwiki.md) [è´¡çŒ®è€…](/å…³äºæœ¬ç«™/home.md)ä¸ªäººåˆ†æçš„å¼€æ”¾ç ”ç©¶æ–‡çŒ®ã€‚å› æ­¤ï¼Œåº”å¸¦ç€å¥åº·çš„æ€€ç–‘æ€åº¦æ¥çœ‹å¾…è¿™äº›å†…å®¹ã€‚*

*å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œè¿™äº›æ•ˆåº”ä¸ä¸€å®šä¼šä»¥å¯é¢„æµ‹æˆ–å¯é çš„æ–¹å¼å‘ç”Ÿï¼Œå°½ç®¡é«˜å‰‚é‡æ›´å®¹æ˜“è¯±å‘å…¨æ–¹ä½çš„æ•ˆåº”ã€‚åŒæ ·ï¼Œ**ä¸è‰¯ååº”**éšç€å‰‚é‡çš„å¢åŠ è€Œå˜å¾—è¶Šæ¥è¶Šå¯èƒ½ï¼Œå¯èƒ½åŒ…æ‹¬**æˆç˜¾ã€ä¸¥é‡ä¼¤å®³æˆ–æ­»äº¡*** â˜ ã€‚

### **èº¯ä½“æ•ˆåº”** ![Child.png](/æ–‡ä»¶/Child.png)

*   **[é•‡é™](/è¯æ•ˆ/é•‡é™.md)**
*   **[èº¯ä½“æ¬£å¿«æ„Ÿ](/è¯æ•ˆ/èº¯ä½“æ¬£å¿«æ„Ÿ.md)** - ä¸[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)æˆ–[æ›²é©¬å¤š](/è¯ç‰©/æ›²é©¬å¤š.md)ç­‰å…¶ä»–é˜¿ç‰‡ç±»è¯ç‰©ç›¸æ¯”ï¼Œè¿™ç§ç‰©è´¨äº§ç”Ÿçš„èº¯ä½“æ¬£å¿«æ„Ÿæä¸ºå¼ºçƒˆã€‚è¿™ç§æ„Ÿè§‰æœ¬èº«å¯ä»¥æè¿°ä¸ºå¼ºçƒˆçš„èº«ä½“èˆ’é€‚ã€æ¸©æš–ã€çˆ±å’Œå¹¸ç¦æ„Ÿã€‚
*   **[è‚Œè‚‰æ¾å¼›](/è¯æ•ˆ/è‚Œè‚‰æ¾å¼›.md)**
*   **[ä¾¿ç§˜](/è¯æ•ˆ/ä¾¿ç§˜.md)**
*   **[å’³å—½æŠ‘åˆ¶](/è¯æ•ˆ/å’³å—½æŠ‘åˆ¶.md)**
*   **[æ€§æ¬²å‡é€€](/è¯æ•ˆ/æ€§æ¬²å‡é€€.md)**
*   **[æ’å°¿å›°éš¾](/è¯æ•ˆ/æ’å°¿å›°éš¾.md)**
*   **[ç˜™ç—’æ„Ÿ](/è¯æ•ˆ/ç˜™ç—’æ„Ÿ.md)**
*   **[æ¶å¿ƒ](/è¯æ•ˆ/æ¶å¿ƒ.md)**
*   **[é•‡ç—›](/è¯æ•ˆ/é•‡ç—›.md)** - è®¸å¤šäººæŠ¥å‘Šè¯´ä»–ä»¬ä»ç„¶æ„è¯†åˆ°ç–¼ç—›ï¼Œä½†ç–¼ç—›ä¸å†å¼•èµ·ä»–ä»¬çš„æ³¨æ„ã€‚
*   **[ç³å­”ç¼©å°](/è¯æ•ˆ/ç³å­”ç¼©å°.md)**
*   **[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)**
*   **[çš®è‚¤æ½®çº¢](/è¯æ•ˆ/çš®è‚¤æ½®çº¢.md)**
*   **[é£Ÿæ¬²æŠ‘åˆ¶](/è¯æ•ˆ/é£Ÿæ¬²æŠ‘åˆ¶.md)**
*   **[æ€§é«˜æ½®æŠ‘åˆ¶](/è¯æ•ˆ/æ€§é«˜æ½®æŠ‘åˆ¶.md)**

### **è®¤çŸ¥æ•ˆåº”** ![User.png](/æ–‡ä»¶/User.png)

*   **[è®¤çŸ¥æ¬£å¿«](/è¯æ•ˆ/è®¤çŸ¥æ¬£å¿«.md)** - å—å•¡äº§ç”Ÿçš„è®¤çŸ¥æ¬£å¿«æ„Ÿæ¯”[å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)æˆ–[æ›²é©¬å¤š](/è¯ç‰©/æ›²é©¬å¤š.md)ç­‰å…¶ä»–é˜¿ç‰‡ç±»è¯ç‰©å¼ºå¾—å¤šï¼Œä½†å¼±äº[æµ·æ´›å› ](/è¯ç‰©/æµ·æ´›å› .md)ã€[æ°¢å¯é…®](/è¯ç‰©/æ°¢å¯é…®.md)å’Œ[ç¾Ÿè€ƒé…®](/è¯ç‰©/ç¾Ÿè€ƒé…®.md)ã€‚è¿™ç§æ„Ÿè§‰å¯ä»¥æè¿°ä¸ºå¼ºå¤§ä¸”åŒ…ç½—ä¸‡è±¡çš„æƒ…æ„Ÿæä¹ã€æ»¡è¶³å’Œå¹¸ç¦æ„Ÿã€‚
*   **[ç„¦è™‘æŠ‘åˆ¶](/è¯æ•ˆ/ç„¦è™‘æŠ‘åˆ¶.md)**
*   **[æ€ç»´å‡ç¼“](/è¯æ•ˆ/æ€ç»´å‡ç¼“.md)**
*   **[å¼ºè¿«æ€§å¼ºåŠ è¯é‡](/è¯æ•ˆ/å¼ºè¿«æ€§å¼ºåŠ è¯é‡.md)**
*   **[æ¢¦å¢ƒå¢å¼º](/è¯æ•ˆ/æ¢¦å¢ƒå¢å¼º.md)**
*   **[æ˜“æ€’](/è¯æ•ˆ/æ˜“æ€’.md)** - è™½ç„¶é˜¿ç‰‡ç±»è¯ç‰©ä»¥æ”¹å–„æƒ…ç»ªçš„èƒ½åŠ›è€Œé—»åï¼Œä½†å®ƒä»¬ä¹Ÿå¯èƒ½äº§ç”Ÿå¢åŠ ç”¨æˆ·å¯¹åˆºæ¿€çš„æ˜“æ€’æ€§çš„åå¸¸æ•ˆæœã€‚è¿™è¡¨ç°ä¸ºå†·æ¼ ä»¥åŠçªç„¶çš„æ„¤æ€’å’Œæ”»å‡»çˆ†å‘ï¼ˆä¿—ç§°â€œé˜¿ç‰‡æ€’â€ï¼‰ã€‚è¿™ç§æƒ…å†µä¼¼ä¹åœ¨ä½“éªŒæ¶ˆé€€æœŸå’Œ/æˆ–å¤§é‡ä½¿ç”¨æ—¶æ›´å¸¸å‘ç”Ÿã€‚

### **è§†è§‰æ•ˆåº”** Eye.png

#### æŠ‘åˆ¶
*   **[å¤è§†](/è¯æ•ˆ/å¤è§†.md)** - åœ¨é«˜å‰‚é‡ä¸‹ï¼Œçœ¼ç›ä¼šæ— æ³•æ§åˆ¶åœ°å¤±ç„¦å’Œé‡æ–°èšç„¦ã€‚è¿™ä¼šäº§ç”Ÿæ¨¡ç³Šæ•ˆæœå’Œå¤è§†ï¼Œæ— è®ºçœ¼ç›èšç„¦åœ¨å“ªé‡Œéƒ½ä¼šå‡ºç°ã€‚è¿™ç§æ„Ÿè§‰å¯èƒ½éå¸¸å¼ºçƒˆï¼Œä»¥è‡³äºæ— æ³•é˜…è¯»æˆ–é©¾é©¶ã€‚

#### å¹»è§‰çŠ¶æ€
*   **[å†…éƒ¨å¹»è§‰](/è¯æ•ˆ/å†…éƒ¨å¹»è§‰.md)** - ç”¨æˆ·åœ¨é‡å‰‚é‡â€œç‚¹å¤´â€ï¼ˆnoddingï¼‰æœŸé—´å¯èƒ½ä¼šç»å†åŠæ„è¯†å’Œ[å…¥ç¡å‰å¹»è§‰](/è¯æ•ˆ/å¹»è§‰.md)çŠ¶æ€ï¼Œè¿™ä¼šå¯¼è‡´ç±»ä¼¼æ¢¦å¢ƒçš„çŠ¶æ€å’Œé«˜è¾¾3çº§çš„[æ„è±¡](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)ã€‚è¿™é€šå¸¸ä¼´éšç€å®šä¹‰ä¸æ¸…çš„[å‡ ä½•å›¾å½¢](/è¯æ•ˆ/è§†è§‰æ•ˆåº”.md)ã€‚

### ä½“éªŒæŠ¥å‘Š

ç›®å‰æˆ‘ä»¬çš„[ä½“éªŒç´¢å¼•](/å…³äºæœ¬ç«™/home.md)ä¸­æ²¡æœ‰æè¿°è¯¥åŒ–åˆç‰©æ•ˆåº”çš„è½¶äº‹æŠ¥å‘Šã€‚å…¶ä»–çš„ä½“éªŒæŠ¥å‘Šå¯ä»¥åœ¨è¿™é‡Œæ‰¾åˆ°ï¼š

*   [Erowid Experience Vaults: Morphine](https://www.erowid.org/experiences/subs/exp_Morphine.shtml)


æ¯’æ€§ä¸å±å®³æ½œåŠ›
---------------------------

ä¸å¤§å¤šæ•°é˜¿ç‰‡ç±»è¯ç‰©ä¸€æ ·ï¼Œæœªæºå‡çš„å—å•¡é™¤ä¾èµ–å’Œä¾¿ç§˜å¤–ï¼Œä¸ä¼šå¼•èµ·è®¸å¤šé•¿æœŸå¹¶å‘ç—‡ã€‚[\[34\]](#cite_note-34) é™¤äº†æå…¶å¼ºçƒˆçš„æˆç˜¾å’Œç”Ÿç†ä¾èµ–å¤–ï¼Œä¸å—å•¡ä½¿ç”¨ç›¸å…³çš„æœ‰å®³æˆ–æ¯’æ€§æ–¹é¢å®Œå…¨ä¸æœªé‡‡å–é€‚å½“çš„ç»™è¯é¢„é˜²æªæ–½ã€è¯ç‰©è¿‡é‡å’Œä½¿ç”¨ä¸çº¯äº§å“æœ‰å…³ã€‚

é‡å‰‚é‡çš„å—å•¡ä¼šå¯¼è‡´[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ï¼Œè¿›è€Œå¯¼è‡´è‡´å‘½æˆ–å±é™©æ°´å¹³çš„ç¼ºæ°§ã€‚è¿™æ˜¯å› ä¸ºå‘¼å¸åå°„è¢«[Âµ-é˜¿ç‰‡å—ä½“](/å—ä½“è›‹ç™½.md)çš„[æ¿€åŠ¨](/å—ä½“-é…ä½“ç»“åˆæ¨¡å‹.md)æ‰€æŠ‘åˆ¶ï¼Œå…¶ç¨‹åº¦ä¸æ‘„å…¥å‰‚é‡æˆæ­£æ¯”ã€‚

å—å•¡ä¹Ÿå¯èƒ½å¼•èµ·æ¶å¿ƒå’Œå‘•åï¼›è®¸å¤šå½’å› äºé˜¿ç‰‡ç±»è¯ç‰©è¿‡é‡çš„æ­»äº¡æ˜¯ç”±æ— æ„è¯†çš„å—å®³è€…å¸å…¥å‘•åç‰©å¼•èµ·çš„ã€‚è¿™æ˜¯å½“ä»°å§çš„æ— æ„è¯†æˆ–åŠæ„è¯†ä½¿ç”¨è€…å‘•ååˆ°å˜´é‡Œå¹¶åœ¨æ­¤è¿‡ç¨‹ä¸­ä¸çŸ¥ä¸è§‰åœ°çª’æ¯æ—¶å‘ç”Ÿçš„ã€‚å¯ä»¥é€šè¿‡ç¡®ä¿ä½¿ç”¨è€…ä¾§å§å¹¶å¤´éƒ¨å‘ä¸‹å€¾æ–œæ¥é¢„é˜²ï¼Œè¿™æ ·åœ¨æ— æ„è¯†å‘•åæ—¶æ°”é“å°±ä¸ä¼šè¢«é˜»å¡ï¼ˆä¹Ÿç§°ä¸º[å¤è‹ä½“ä½](/è¯ç‰©åº”å¯¹æªæ–½/åº”æ€¥å¤„ç†.md)ï¼‰ã€‚

å¼ºçƒˆå»ºè®®åœ¨ä½¿ç”¨æ­¤ç‰©è´¨æ—¶é‡‡å–[ä¼¤å®³å‡å°‘æªæ–½](/è¯ç‰©åº”å¯¹æªæ–½/home.md)ã€‚

### ä¾èµ–æ€§ä¸æ»¥ç”¨æ½œåŠ›

ä¸å…¶ä»–åŸºäºé˜¿ç‰‡çš„æ­¢ç—›è¯ä¸€æ ·ï¼Œé•¿æœŸä½¿ç”¨å—å•¡è¢«è®¤ä¸ºææ˜“æˆç˜¾ï¼Œå¹¶ä¸”èƒ½å¤Ÿå¼•èµ·ç”Ÿç†å’Œå¿ƒç†ä¾èµ–ã€‚å½“äº§ç”Ÿç”Ÿç†ä¾èµ–åï¼Œå¦‚æœä¸€ä¸ªäººçªç„¶åœæ­¢ä½¿ç”¨ï¼Œå¯èƒ½ä¼šå‡ºç°[æˆ’æ–­ç—‡çŠ¶](/è¯ç‰©åº”å¯¹æªæ–½/è¯ç‰©æˆ’é™¤/æˆ’æ–­ååº”.md)ã€‚

éšç€é•¿æœŸä½¿ç”¨ï¼Œå¯¹å—å•¡è®¸å¤šæ•ˆåº”çš„è€å—æ€§ä¼šå¢å¼ºï¼ŒåŒ…æ‹¬æ²»ç–—æ•ˆæœã€‚è¿™å¯¼è‡´ä½¿ç”¨è€…å¿…é¡»æœç”¨è¶Šæ¥è¶Šå¤§çš„å‰‚é‡æ‰èƒ½è¾¾åˆ°ç›¸åŒçš„æ•ˆæœã€‚è¿™ç§è€å—æ€§çš„å‘å±•é€Ÿåº¦å¯¹äºä¸åŒçš„æ•ˆåº”æ˜¯ä¸åŒçš„ï¼Œå¯¹å¯¼è‡´ä¾¿ç§˜æ•ˆåº”çš„è€å—æ€§å‘å±•ç‰¹åˆ«ç¼“æ…¢ã€‚å—å•¡ä¸æ‰€æœ‰å…¶ä»–[é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)è¯ç‰©å­˜åœ¨äº¤å‰è€å—ï¼Œè¿™æ„å‘³ç€åœ¨æœç”¨å—å•¡åï¼Œæ‰€æœ‰[é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)è¯ç‰©çš„æ•ˆæœéƒ½ä¼šå‡å¼±ã€‚

åœ¨åœæ­¢ä½¿ç”¨å’Œ[å¤å¸](/è¯ç‰©åº”å¯¹æªæ–½/è¯ç‰©æˆ’é™¤/æˆ’æ–­ååº”.md)ä¸€æ®µæ—¶é—´åï¼Œè‡´å‘½çš„é˜¿ç‰‡ç±»è¯ç‰©è¿‡é‡é£é™©æ€¥å‰§ä¸Šå‡ï¼Œä¸»è¦æ˜¯å› ä¸ºè€å—æ€§é™ä½ã€‚[\[35\]](#cite_note-35) ä¸ºäº†åº”å¯¹è¿™ç§è€å—æ€§ç¼ºå¤±ï¼Œå¦‚æœå¤å¸ï¼Œä»…ä½¿ç”¨å¹³æ—¶[å‰‚é‡](/è¯ç‰©æ¦‚è¿°.md)çš„ä¸€å°éƒ¨åˆ†æ›´å®‰å…¨ã€‚ç ”ç©¶è¿˜å‘ç°ï¼Œæ‰€å¤„çš„ç¯å¢ƒåœ¨é˜¿ç‰‡ç±»è¯ç‰©è€å—æ€§ä¸­èµ·ä½œç”¨ã€‚åœ¨ä¸€é¡¹ç§‘å­¦ç ”ç©¶ä¸­ï¼Œå…·æœ‰ç›¸åŒæµ·æ´›å› ç»™è¯å²çš„å¤§é¼ å¦‚æœåœ¨ä¸è¯ç‰©æ— å…³çš„ç¯å¢ƒä¸­æ¥å—å‰‚é‡ï¼Œå…¶æ­»äº¡çš„å¯èƒ½æ€§æ˜¾è‘—é«˜äºåœ¨ç†Ÿæ‚‰çš„ç¯å¢ƒä¸­ã€‚[\[36\]](#cite_note-36)

### å±é™©çš„ç›¸äº’ä½œç”¨

å—å•¡ä¸å…¶å®ƒ[æŠ‘åˆ¶å‰‚](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/æŠ‘åˆ¶å‰‚.md)æ··åˆä½¿ç”¨æ˜¯å±é™©çš„ï¼Œå› ä¸ºè®¸å¤šæŠ¥å‘Šä¸ºè¿‡é‡çš„æ­»äº¡æ¡ˆä¾‹æ˜¯ç”±ä¸[é…’ç²¾](/è¯ç‰©/é…’ç²¾.md)æˆ–[è‹¯äºŒæ°®å“ç±»è¯ç‰©](/è‹¯äºŒæ°®å“ç±»ç‰©è´¨.md)ç­‰å…¶ä»–æŠ‘åˆ¶å‰‚è¯ç‰©çš„ç›¸äº’ä½œç”¨å¼•èµ·çš„ï¼Œè¿™ä¼šå¯¼è‡´å±é™©çš„é«˜æ°´å¹³[å‘¼å¸æŠ‘åˆ¶](/è¯æ•ˆ/å‘¼å¸æŠ‘åˆ¶.md)ã€‚[\[37\]](#cite_note-37)

***è­¦å‘Šï¼š*** *è®¸å¤šç²¾ç¥æ´»æ€§ç‰©è´¨å•ç‹¬ä½¿ç”¨æ—¶ç›¸å¯¹å®‰å…¨ï¼Œä½†å½“ä¸æŸäº›å…¶ä»–ç‰©è´¨ç»“åˆä½¿ç”¨æ—¶ï¼Œå¯èƒ½ä¼šçªç„¶å˜å¾—å±é™©ç”šè‡³å±åŠç”Ÿå‘½ã€‚ä»¥ä¸‹åˆ—è¡¨æä¾›äº†ä¸€äº›å·²çŸ¥çš„å±é™©ç›¸äº’ä½œç”¨ï¼ˆå°½ç®¡ä¸ä¿è¯åŒ…å«æ‰€æœ‰ç›¸äº’ä½œç”¨ï¼‰ã€‚*

*åŠ¡å¿…è¿›è¡Œç‹¬ç«‹ç ”ç©¶ï¼ˆä¾‹å¦‚ [Google](https://www.google.com), [DuckDuckGo](https://www.duckduckgo.com), [PubMed](https://pubmed.ncbi.nlm.nih.gov/)ï¼‰ä»¥ç¡®ä¿ä¸¤ç§æˆ–å¤šç§ç‰©è´¨çš„ç»„åˆå¯ä»¥å®‰å…¨é£Ÿç”¨ã€‚éƒ¨åˆ†åˆ—å‡ºçš„ç›¸äº’ä½œç”¨æ¥è‡ª [TripSit](https://combo.tripsit.me)ã€‚*

*   **é…’ç²¾** - ä¸¤ç§ç‰©è´¨éƒ½ä¼šå¢å¼ºå¯¹æ–¹å¼•èµ·çš„å…±æµå¤±è°ƒå’Œé•‡é™ä½œç”¨ï¼Œåœ¨é«˜å‰‚é‡ä¸‹å¯èƒ½å¯¼è‡´æ„å¤–çš„æ„è¯†ä¸§å¤±ã€‚å°†å—å½±å“çš„æ‚£è€…ç½®äºå¤è‹ä½“ä½ï¼Œä»¥é˜²æ­¢å› å‘•åè¿‡å¤šè€Œå¸å…¥ã€‚è®°å¿†æ–­ç‰‡ï¼ˆBlackoutsï¼‰å¾ˆå¯èƒ½å‘ç”Ÿã€‚
*   **å…´å¥‹å‰‚** - å…´å¥‹å‰‚ä¼šå¢åŠ å‘¼å¸é¢‘ç‡ï¼Œè¿™ä½¿å¾—ä½¿ç”¨è€…å¯ä»¥ä½¿ç”¨æ¯”é€šå¸¸æƒ…å†µä¸‹æ›´é«˜å‰‚é‡çš„é˜¿ç‰‡ç±»è¯ç‰©ã€‚å¦‚æœå…´å¥‹å‰‚å…ˆå¤±æ•ˆï¼Œé˜¿ç‰‡ç±»è¯ç‰©å¯èƒ½ä¼šå‹å€’ä½¿ç”¨è€…å¹¶å¯¼è‡´å‘¼å¸åœæ­¢ã€‚
*   **è‹¯äºŒæ°®å“ç±»è¯ç‰©** - ä¸­æ¢ç¥ç»ç³»ç»Ÿå’Œ/æˆ–å‘¼å¸æŠ‘åˆ¶ä½œç”¨å¯èƒ½ä¼šç›¸åŠ æˆ–ååŒå‡ºç°ã€‚è¿™ä¸¤ç§ç‰©è´¨ä¼šå¼ºçƒˆä¸”ä¸å¯é¢„æµ‹åœ°ç›¸äº’å¢å¼ºï¼Œéå¸¸è¿…é€Ÿåœ°å¯¼è‡´æ„è¯†ä¸§å¤±ã€‚åœ¨æ„è¯†ä¸§å¤±æœŸé—´ï¼Œå¦‚æœä¸ç½®äºå¤è‹ä½“ä½ï¼Œæœ‰å‘•åç‰©å¸å…¥çš„é£é™©ã€‚å¾ˆå¯èƒ½å‘ç”Ÿæ–­ç‰‡/è®°å¿†ä¸§å¤±ã€‚
*   **å³ç¾æ²™èŠ¬ (DXM)** - é€šå¸¸è®¤ä¸ºæ˜¯æœ‰æ¯’çš„ã€‚å·²è§‚å¯Ÿåˆ°ä¸­æ¢ç¥ç»ç³»ç»ŸæŠ‘åˆ¶ã€å‘¼å¸å›°éš¾ã€å¿ƒè„é—®é¢˜å’Œè‚è„æ¯’æ€§ã€‚æ­¤å¤–ï¼Œå¦‚æœæœç”¨ DXMï¼Œä»–ä»¬å¯¹é˜¿ç‰‡ç±»è¯ç‰©çš„è€å—æ€§ä¼šç•¥å¾®é™ä½ï¼Œä»è€Œå¼•èµ·é¢å¤–çš„ååŒæ•ˆåº”ã€‚
*   **GHB/GBL** - è¿™ä¸¤ç§ç‰©è´¨ä¼šå¼ºçƒˆä¸”ä¸å¯é¢„æµ‹åœ°ç›¸äº’å¢å¼ºï¼Œéå¸¸è¿…é€Ÿåœ°å¯¼è‡´æ„è¯†ä¸§å¤±ã€‚åœ¨æ„è¯†ä¸§å¤±æœŸé—´ï¼Œå¦‚æœä¸ç½®äºå¤è‹ä½“ä½ï¼Œæœ‰å‘•åç‰©å¸å…¥çš„é£é™©ã€‚
*   **æ°¯èƒºé…®** - ä¸¤ç§ç‰©è´¨éƒ½æœ‰å‘•åå’Œæ„è¯†ä¸§å¤±çš„é£é™©ã€‚å¦‚æœä½¿ç”¨è€…åœ¨å—å½±å“æ—¶å¤±å»çŸ¥è§‰ï¼Œå¦‚æœä¸ç½®äºå¤è‹ä½“ä½ï¼Œåˆ™å­˜åœ¨ä¸¥é‡çš„å‘•åç‰©å¸å…¥é£é™©ã€‚
*   **MAOIs** - å•èƒºæ°§åŒ–é…¶æŠ‘åˆ¶å‰‚ (MAOIs) ä¸æŸäº›é˜¿ç‰‡ç±»è¯ç‰©åˆç”¨ä¸ç½•è§çš„ä¸¥é‡ä¸è‰¯ååº”æŠ¥å‘Šæœ‰å…³ã€‚ä¼¼ä¹æœ‰ä¸¤ç§ç±»å‹çš„ç›¸äº’ä½œç”¨ï¼Œä¸€ç§æ˜¯å…´å¥‹æ€§çš„ï¼Œä¸€ç§æ˜¯æŠ‘åˆ¶æ€§çš„ã€‚å…´å¥‹æ€§ååº”çš„ç—‡çŠ¶å¯èƒ½åŒ…æ‹¬æ¿€åŠ¨ã€å¤´ç—›ã€å¤šæ±—ã€é«˜çƒ­ã€æ½®çº¢ã€é¢¤æŠ–ã€è‚Œé˜µæŒ›ã€åƒµç¡¬ã€éœ‡é¢¤ã€è…¹æ³»ã€é«˜è¡€å‹ã€å¿ƒåŠ¨è¿‡é€Ÿã€ç™«ç—«å‘ä½œå’Œæ˜è¿·ã€‚æœ‰äº›ç—…ä¾‹å·²å‘ç”Ÿæ­»äº¡ã€‚
*   **MXE** - MXE å¯ä»¥å¢å¼ºé˜¿ç‰‡ç±»è¯ç‰©çš„æ•ˆæœï¼Œä½†ä¹Ÿä¼šå¢åŠ å‘¼å¸æŠ‘åˆ¶å’Œå™¨å®˜æ¯’æ€§çš„é£é™©ã€‚
*   **æ°§åŒ–äºšæ°®** - ä¸¤ç§ç‰©è´¨éƒ½ä¼šå¢å¼ºå¯¹æ–¹å¼•èµ·çš„å…±æµå¤±è°ƒå’Œé•‡é™ä½œç”¨ï¼Œåœ¨é«˜å‰‚é‡ä¸‹å¯èƒ½å¯¼è‡´æ„å¤–çš„æ„è¯†ä¸§å¤±ã€‚åœ¨æ„è¯†ä¸§å¤±æœŸé—´ï¼Œå¦‚æœä¸ç½®äºå¤è‹ä½“ä½ï¼Œæœ‰å‘•åç‰©å¸å…¥çš„é£é™©ã€‚è®°å¿†æ–­ç‰‡å¾ˆå¸¸è§ã€‚
*   **PCP** - PCP å¯èƒ½é™ä½é˜¿ç‰‡ç±»è¯ç‰©çš„è€å—æ€§ï¼Œå¢åŠ è¿‡é‡é£é™©ã€‚
*   **æ›²é©¬å¤š** - å¢åŠ ç™«ç—«å‘ä½œçš„é£é™©ã€‚æ›²é©¬å¤šæœ¬èº«å·²çŸ¥ä¼šè¯±å‘ç™«ç—«å‘ä½œï¼Œå¹¶ä¸”å¯èƒ½ä¸å…¶ä»–é˜¿ç‰‡ç±»è¯ç‰©å¯¹ç™«ç—«é˜ˆå€¼äº§ç”Ÿç›¸åŠ æ•ˆåº”ã€‚ä¸­æ¢ç¥ç»ç³»ç»Ÿå’Œ/æˆ–å‘¼å¸æŠ‘åˆ¶ä½œç”¨å¯èƒ½ä¼šç›¸åŠ æˆ–ååŒå‡ºç°ã€‚
*   **è‘¡è„æŸš** - è™½ç„¶è‘¡è„æŸšä¸å…·æœ‰ç²¾ç¥æ´»æ€§ï¼Œä½†å®ƒå¯èƒ½ä¼šå½±å“æŸäº›é˜¿ç‰‡ç±»è¯ç‰©çš„ä»£è°¢ã€‚æ›²é©¬å¤šã€ç¾Ÿè€ƒé…®å’ŒèŠ¬å¤ªå°¼ä¸»è¦ç”± CYP3A4 é…¶ä»£è°¢ï¼Œè¯¥é…¶è¢«è‘¡è„æŸšæ±å¼ºåŠ›æŠ‘åˆ¶[\[38\]](#cite_note-Ershad2020-38)ã€‚è¿™å¯èƒ½å¯¼è‡´è¯ç‰©ä»ä½“å†…æ¸…é™¤çš„æ—¶é—´æ›´é•¿ï¼Œé‡å¤ç»™è¯å¯èƒ½ä¼šå¢åŠ æ¯’æ€§ã€‚ç¾æ²™é…®ä¹Ÿå¯èƒ½å—åˆ°å½±å“[\[38\]](#cite_note-Ershad2020-38)ã€‚å¯å¾…å› å’Œæ°¢å¯é…®ç”± CYP2D6 ä»£è°¢ã€‚æœç”¨æŠ‘åˆ¶ CYP2D6 è¯ç‰©çš„äººï¼Œæˆ–å› åŸºå› çªå˜è€Œç¼ºä¹è¯¥é…¶çš„äººï¼Œå¯¹å¯å¾…å› æ²¡æœ‰ååº”ï¼Œå› ä¸ºå®ƒä¸èƒ½ä»£è°¢æˆæ´»æ€§äº§ç‰©ï¼šå—å•¡ã€‚

æ³•å¾‹åœ°ä½
------------

åœ¨å›½é™…ä¸Šï¼Œå—å•¡æ˜¯ã€Šéº»é†‰å“å•ä¸€å…¬çº¦ã€‹ä¸‹çš„ä¸€ç±»ï¼ˆSchedule Iï¼‰è¯ç‰©ã€‚[\[39\]](#cite_note-39) å®ƒåœ¨ä¸–ç•Œå«ç”Ÿç»„ç»‡çš„åŸºæœ¬è¯ç‰©æ ‡å‡†æ¸…å•ä¸Šï¼Œè¿™æ˜¯åŸºæœ¬å«ç”Ÿç³»ç»Ÿæ‰€éœ€çš„æœ€é‡è¦è¯ç‰©æ¸…å•ã€‚[\[40\]](#cite_note-40)

*   **æ¾³å¤§åˆ©äºšï¼š** å—å•¡åœ¨å„å·å’Œé¢†åœ°çš„æ¯’è¯æ³•æ¡ˆä¸‹è¢«å½’ç±»ä¸ºé™„è¡¨8ï¼ˆSchedule 8ï¼‰è¯ç‰©ã€‚
*   **å¥¥åœ°åˆ©ï¼š** æ ¹æ® AMGï¼ˆå¥¥åœ°åˆ©è¯å“æ³•ï¼‰ï¼Œå—å•¡ç”¨äºåŒ»ç–—æ˜¯åˆæ³•çš„ï¼›æ ¹æ® SMGï¼ˆå¥¥åœ°åˆ©éº»é†‰å“æ³•ï¼‰ï¼Œåœ¨æ²¡æœ‰å¤„æ–¹çš„æƒ…å†µä¸‹é”€å”®æˆ–æŒæœ‰æ˜¯éæ³•çš„ã€‚
*   **åŠ æ‹¿å¤§ï¼š** å—å•¡åœ¨ã€Šç®¡åˆ¶è¯ç‰©å’Œç‰©è´¨æ³•ã€‹ä¸‹è¢«å½’ç±»ä¸ºé™„è¡¨Iè¯ç‰©ã€‚[\[41\]](#cite_note-41)
*   **æ³•å›½ï¼š** æ ¹æ®1970å¹´12æœˆçš„æ³•å›½ç®¡åˆ¶ç‰©è´¨æ³•ï¼Œå—å•¡å±äºæœ€ä¸¥æ ¼çš„ç®¡åˆ¶ç‰©è´¨é™„è¡¨ã€‚
*   **å¾·å›½ï¼š** å—å•¡æ˜¯ BtMG é™„è¡¨ III ä¸‹çš„ç®¡åˆ¶ç‰©è´¨ã€‚å®ƒåªèƒ½é€šè¿‡éº»é†‰å“å¤„æ–¹å•å¼€å…·ã€‚[\[42\]](#cite_note-42)
*   **æ—¥æœ¬ï¼š** å—å•¡æ ¹æ®ã€Šéº»é†‰åŠç²¾ç¥è¯ç‰©å–ç¼”æ³•ã€‹è¢«å½’ç±»ä¸ºéº»é†‰å“ã€‚[\[43\]](#cite_note-43)
*   **è·å…°ï¼š** å—å•¡åœ¨ã€Šé¸¦ç‰‡æ³•ã€‹ä¸‹è¢«å½’ç±»ä¸ºæ¸…å•1è¯ç‰©ã€‚
*   **ä¿„ç½—æ–¯ï¼š** å—å•¡æ˜¯é™„è¡¨IIç®¡åˆ¶ç‰©è´¨ã€‚[\[44\]](#cite_note-44)
*   **ç‘å…¸ï¼š** å—å•¡ç”¨äºåŒ»ç–—æ˜¯åˆæ³•çš„ï¼Œå¹¶ä¸”æ˜¯ç®¡åˆ¶ç‰©è´¨ã€‚[\[45\]](#cite_note-45)
*   **ç‘å£«ï¼š** å—å•¡æ˜¯ Verzeichnis A ä¸­æ˜ç¡®å‘½åçš„ç®¡åˆ¶ç‰©è´¨ã€‚å…è®¸åŒ»ç–—ä½¿ç”¨ã€‚[\[46\]](#cite_note-46)
*   **åœŸè€³å…¶ï¼š** å—å•¡æ˜¯ä»…é™â€œçº¢å¤„æ–¹â€çš„ç‰©è´¨[\[47\]](#cite_note-47)ï¼Œåœ¨æ²¡æœ‰å¤„æ–¹çš„æƒ…å†µä¸‹é”€å”®æˆ–æŒæœ‰æ˜¯éæ³•çš„ã€‚
*   **è‹±å›½ï¼š** å—å•¡åœ¨ã€Š1971å¹´æ»¥ç”¨è¯ç‰©æ³•ã€‹ä¸‹è¢«åˆ—ä¸ºAç±»è¯ç‰©ï¼Œåœ¨ã€Š2001å¹´æ»¥ç”¨è¯ç‰©æ¡ä¾‹ã€‹ä¸‹è¢«åˆ—ä¸ºé™„è¡¨2ç®¡åˆ¶è¯ç‰©ã€‚[\[48\]](#cite_note-48)[\[49\]](#cite_note-49)
*   **ç¾å›½ï¼š** æ ¹æ®ã€Šç®¡åˆ¶ç‰©è´¨æ³•ã€‹ï¼Œå—å•¡è¢«å½’ç±»ä¸ºé™„è¡¨IIç®¡åˆ¶ç‰©è´¨ï¼Œä¸»è¦è¡Œæ”¿ç®¡åˆ¶ç‰©è´¨ä»£ç  (ACSCN) ä¸º ACSCN 9300ã€‚ç¾å›½çš„å—å•¡è¯å“å—å¹´åº¦ç”Ÿäº§é…é¢é™åˆ¶ï¼›ç”¨äºæç¨€é…æ–¹çš„å—å•¡ç”Ÿäº§åŠå…¶ä½œä¸ºè½¬åŒ–ä¸ºå…¶ä»–è¯ç‰©çš„ä¸­é—´ä½“æˆ–åŒ–å­¦å‰ä½“çš„ç”Ÿäº§ä¸åŒ…æ‹¬åœ¨ç¾å›½ç”Ÿäº§é…é¢å†…ã€‚[\[26\]](#cite_note-Busse2008-26)

å¦è§
--------

*   [è´Ÿè´£ä»»çš„ä½¿ç”¨](/å…³äºæœ¬ç«™/è§‚å‰æé†’.md)
*   [é˜¿ç‰‡ç±»](/æ–‡æ¡£/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)
*   [å¯å¾…å› ](/è¯ç‰©/å¯å¾…å› .md)
*   [æµ·æ´›å› ](/è¯ç‰©/æµ·æ´›å› .md)
*   [çº³æ´›é…®](/è¯ç‰©åˆ†ç±»/é˜¿ç‰‡ç±»è¯ç‰©.md)

å¤–éƒ¨é“¾æ¥
--------------

*   [Morphine (Wikipedia)](http://en.wikipedia.org/wiki/Morphine)
*   [Morphine (Erowid Vault)](https://www.erowid.org/pharms/morphine/)
*   [Morphine (Isomer Design)](https://isomerdesign.com/PiHKAL/explore.php?id=9155)
*   [Morphine (DrugBank)](https://go.drugbank.com/drugs/DB00295)
*   [Morphine (Drugs.com)](https://www.drugs.com/morphine.html)
*   [Morphine (Drugs-Forum)](https://drugs-forum.com/wiki/Morphine)

æ–‡çŒ®
----------

*   Schmidt, H., Vormfelde, S. V., Klinder, K., Gundert-Remy, U., Gleiter, C. H., Skopp, G., Aderjan, R. and Fuhr, U. (2002), Affinities of Dihydrocodeine and its Metabolites to Opioid Receptors. Pharmacology & Toxicology, 91: 57â€“63. <https://doi.org/10.1034/j.1600-0773.2002.910203.x>
*   Koch T, HÃ¶llt V (2008). Role of receptor internalization in opioid tolerance and dependence. Pharmacol. Ther. 117 (2): 199â€“206. <https://doi.org/10.1016/j.pharmthera.2007.10.003>
*   Pert, C. B., Pasternak, G., & Snyder, S. H. (1973). Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain. Science, 182(4119), 1359-1361. <https://doi.org/10.1126/science.182.4119.1359>
*   Friswell J, Phillips C, Holding J, Morgan CJ, Brandner B, Curran HV (2008). Acute effects of opioids on memory functions of healthy men and women. Psychopharmacology (Berl.). 198 (2): 243â€“50. <https://doi.org/10.1007/s00213-008-1123-x>.
*   Stefano GB, PtÃ¡Äek R, KuÅ¾elovÃ¡ H, Kream RM (2012). Endogenous morphine: up-to-date review (2011). Folia Biol. (Praha). 58 (2): 49â€“56. PMID 22578954. *Positive evolutionary pressure has apparently preserved the ability to synthesize chemically authentic morphine, albeit in homeopathic concentrations, throughout animal phyla.*

å‚è€ƒæ–‡çŒ®
----------

1.  [â†‘](#cite_ref-tripsit_1-0) [*Risks of Combining Depressants - TripSit*](https://tripsit.me/combining-depressants/)Â 
2.  [â†‘](#cite_ref-Medsafe_2-0) "[*Medsafe*](https://www.medsafe.govt.nz/profs/datasheet/m/morphinesulphateinjbiomed.pdf) (PDF)Â 
3.  [â†‘](#cite_ref-FDA_3-0) "[*FDA*](https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202515s000lbl.pdf) (PDF)Â 
4.  [â†‘](#cite_ref-South_Australian_Neonatal_Medication_Guidelines_4-0) "[*South Australian Neonatal Medication Guidelines*](https://www.sahealth.sa.gov.au/wps/wcm/connect/4f1073004cd7e4b4ba11baa496684d9f/Morphine_Neo_v4_4.pdf?MOD=AJPERES&CACHEID=ROOTWORKSPACE-4f1073004cd7e4b4ba11baa496684d9f-p4cjAwk) (PDF)Â 
5.  [â†‘](#cite_ref-Pfizer_5-0) "[*Pfizer*](https://www.pfizermedicalinformation.com/morphine-1/dosage-admin)Â 
6.  [â†‘](#cite_ref-6) Dicpinigaitis, P. V., Morice, A. H., Birring, S. S., McGarvey, L., Smith, J. A., Canning, B. J., Page, C. P. (April 2014). Sibley, D. R., ed. ["Antitussive Drugsâ€”Past, Present, and Future"](http://pharmrev.aspetjournals.org/lookup/doi/10.1124/pr.111.005116). *Pharmacological Reviews*. **66** (2): 468â€“512. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1124/pr.111.005116](//doi.org/10.1124%2Fpr.111.005116). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0031-6997](//www.worldcat.org/issn/0031-6997).Â 
7.  â†‘ [7.0](#cite_ref-Sertiirner1806_7-0) [7.1](#cite_ref-Sertiirner1806_7-1) Sertiirner FW. Darstellung der reinen Mohnsaure (Opium-
    saure) nebst einer chemischen Untersuchung des Opiums
    mit vorziiglicher Hinsicht auf einen darin neuen Stoff und
    die dahin gehoringen Bemerkungen. Trommdorfs J Pharm 1806: 14: 47-93
8.  [â†‘](#cite_ref-8) Morphine Sulfate | <http://www.drugs.com/monograph/morphine-sulfate.html>
9.  [â†‘](#cite_ref-9) Beaty, J. H., Kasser, J. R. (2010). *Rockwood and Wilkinsâ€™ Fractures in Children*. Lippincott Williams & Wilkins. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9781582557847](http://en.wikipedia.org/wiki/Special:BookSources/9781582557847 "wikipedia:Special:BookSources/9781582557847").Â 
10. [â†‘](#cite_ref-10) Anda Approval Package <https://www.accessdata.fda.gov/drugsatfda_docs/anda/2011/200812Orig1s000.pdf>
11. [â†‘](#cite_ref-11) Morphine Sulfate | <http://www.drugs.com/monograph/morphine-sulfate.html>
12. [â†‘](#cite_ref-12) Luch, A. (3 April 2009). *Molecular, Clinical and Environmental Toxicology: Volume 1: Molecular Toxicology*. Springer Science & Business Media. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9783764383367](http://en.wikipedia.org/wiki/Special:BookSources/9783764383367 "wikipedia:Special:BookSources/9783764383367").Â 
13. [â†‘](#cite_ref-13) Lugo, R. A., Kern, S. E. (January 2002). ["Clinical Pharmacokinetics of Morphine"](http://www.tandfonline.com/doi/full/10.1080/J354v16n04_02). *Journal of Pain & Palliative Care Pharmacotherapy*. **16** (4): 5â€“18. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1080/J354v16n04_02](//doi.org/10.1080%2FJ354v16n04_02). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1536-0288](//www.worldcat.org/issn/1536-0288).Â 
14. â†‘ [14.0](#cite_ref-Mosher2013_14-0) [14.1](#cite_ref-Mosher2013_14-1) Mosher, C. J., Akins, S. M. (22 August 2013). *Drugs and Drug Policy: The Control of Consciousness Alteration*. SAGE Publications. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9781483321882](http://en.wikipedia.org/wiki/Special:BookSources/9781483321882 "wikipedia:Special:BookSources/9781483321882").Â 
15. [â†‘](#cite_ref-15) Fisher, G. L., Roget, N. A. (11 November 2008). *Encyclopedia of Substance Abuse Prevention, Treatment, and Recovery*. SAGE Publications. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9781452266015](http://en.wikipedia.org/wiki/Special:BookSources/9781452266015 "wikipedia:Special:BookSources/9781452266015").Â 
16. â†‘ [16.0](#cite_ref-Courtwright2009_16-0) [16.1](#cite_ref-Courtwright2009_16-1) Courtwright, D. T. (30 June 2009). *Forces of Habit: Drugs and the Making of the Modern World*. Harvard University Press. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9780674029903](http://en.wikipedia.org/wiki/Special:BookSources/9780674029903 "wikipedia:Special:BookSources/9780674029903").Â 
17. [â†‘](#cite_ref-17) ÎºÏÎ´ÎµÎ¹Î± Meaning <https://www.wordsense.eu/%CE%BA%CF%8E%CE%B4%CE%B5%CE%B9%CE%B1/>
18. [â†‘](#cite_ref-18) Gulland, J. M., Robinson, R. (1923). ["CXII.â€”The morphine group. Part I. A discussion of the constitutional problem"](http://xlink.rsc.org/?DOI=CT9232300980). *J. Chem. Soc., Trans*. **123** (0): 980â€“998. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1039/CT9232300980](//doi.org/10.1039%2FCT9232300980). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0368-1645](//www.worldcat.org/issn/0368-1645).Â 
19. [â†‘](#cite_ref-19) Duin, C. F. van, Robinson, R., Smith, J. C. (1926). ["CXXV.â€”The morphine group. Part III. The constitution of neopine"](http://xlink.rsc.org/?DOI=JR9262900903). *J. Chem. Soc*. **129** (0): 903â€“908. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1039/JR9262900903](//doi.org/10.1039%2FJR9262900903). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0368-1769](//www.worldcat.org/issn/0368-1769).Â 
20. [â†‘](#cite_ref-20) SchÃ¶pf, C. (1927). ["Die Konstitution der Morphiumalkaloide"](https://onlinelibrary.wiley.com/doi/10.1002/jlac.19274520114). *Justus Liebigâ€™s Annalen der Chemie*. **452** (1): 211â€“267. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1002/jlac.19274520114](//doi.org/10.1002%2Fjlac.19274520114). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0075-4617](//www.worldcat.org/issn/0075-4617).Â 
21. [â†‘](#cite_ref-21) Gates, M., Tschudi, G. (April 1956). ["The Synthesis of Morphine"](https://pubs.acs.org/doi/abs/10.1021/ja01588a033). *Journal of the American Chemical Society*. **78** (7): 1380â€“1393. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1021/ja01588a033](//doi.org/10.1021%2Fja01588a033). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0002-7863](//www.worldcat.org/issn/0002-7863).Â 
22. [â†‘](#cite_ref-22) *Narcotic Drugs Estimated World Requirements for 2008, Statistics for 2006*. United Nations Pubns. 2008. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9789210481199](http://en.wikipedia.org/wiki/Special:BookSources/9789210481199 "wikipedia:Special:BookSources/9789210481199").Â 
23. â†‘ [23.0](#cite_ref-:1_23-0) [23.1](#cite_ref-:1_23-1) Narcotic Drugs StupÃ©fiants Estupefacientes 2014 | <https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2014/Narcotic_Drugs_Report_2014.pdf>
24. [â†‘](#cite_ref-24) <https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2014/Narcotic_Drugs_Report_2014.pdf>
25. [â†‘](#cite_ref-25) Narcotic Drugs StupÃ©fiants Estupefacientes 2014 | <https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2014/Narcotic_Drugs_Report_2014.pdf>
26. â†‘ [26.0](#cite_ref-Busse2008_26-0) [26.1](#cite_ref-Busse2008_26-1) Busse, G. D. (2008). [*Morphine*](http://ebooks.infobasepublishing.com/View.aspx?ISBN=9781438102115). Chelsea. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9781438102115](http://en.wikipedia.org/wiki/Special:BookSources/9781438102115 "wikipedia:Special:BookSources/9781438102115").Â 
27. [â†‘](#cite_ref-27) Karch, S. B. (2007). *Drug abuse handbook*. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9780429245114](http://en.wikipedia.org/wiki/Special:BookSources/9780429245114 "wikipedia:Special:BookSources/9780429245114").Â 
28. [â†‘](#cite_ref-28) Stefano, G. B., Goumon, Y., Casares, F., Cadet, P., Fricchione, G. L., Rialas, C., Peter, D., Sonetti, D., Guarna, M., Welters, I. D., Bianchi, E. (September 2000). ["Endogenous morphine"](https://linkinghub.elsevier.com/retrieve/pii/S0166223600016118). *Trends in Neurosciences*. **23** (9): 436â€“442. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1016/S0166-2236(00)01611-8](//doi.org/10.1016%2FS0166-2236%2800%2901611-8). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0166-2236](//www.worldcat.org/issn/0166-2236).Â 
29. [â†‘](#cite_ref-29) Holmquist, G. L. (April 2009). ["Opioid Metabolism and Effects of Cytochrome P450"](https://academic.oup.com/painmedicine/article-lookup/doi/10.1111/j.1526-4637.2009.00596.x). *Pain Medicine*. **10** (suppl 1): S20â€“S29. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1111/j.1526-4637.2009.00596.x](//doi.org/10.1111%2Fj.1526-4637.2009.00596.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1526-2375](//www.worldcat.org/issn/1526-2375).Â 
30. â†‘ [30.0](#cite_ref-:2_30-0) [30.1](#cite_ref-:2_30-1) Christrup, L. L. (January 1997). ["Morphine metabolites"](https://onlinelibrary.wiley.com/doi/10.1111/j.1399-6576.1997.tb04625.x). *Acta Anaesthesiologica Scandinavica*. **41** (1): 116â€“122. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1111/j.1399-6576.1997.tb04625.x](//doi.org/10.1111%2Fj.1399-6576.1997.tb04625.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0001-5172](//www.worldcat.org/issn/0001-5172).Â 
31. [â†‘](#cite_ref-Schmidt2002_31-0) Schmidt, H., Vormfelde, S. V., Klinder, K., Gundert-Remy, U., Gleiter, C. H., Skopp, G., Aderjan, R., Fuhr, U. (August 2002). ["Affinities of Dihydrocodeine and its Metabolites to Opioid Receptors: DIHYDROCODEINE BINDING TO OPIOID RECEPTORS"](http://doi.wiley.com/10.1034/j.1600-0773.2002.910203.x). *Pharmacology & Toxicology*. **91** (2): 57â€“63. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1034/j.1600-0773.2002.910203.x](//doi.org/10.1034%2Fj.1600-0773.2002.910203.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0901-9928](//www.worldcat.org/issn/0901-9928).Â 
32. [â†‘](#cite_ref-32) Illum, L., Watts, P., Fisher, A. N., Hinchcliffe, M., Norbury, H., Jabbal-Gill, I., Nankervis, R., & Davis, S. S. (2002). [Intranasal delivery of morphine.](https://doi.org/10.1124/jpet.301.1.391) *The Journal of pharmacology and experimental therapeutics*, *301*(1), 391â€“400.
33. [â†‘](#cite_ref-33) Hamedi, H., Moradi, S., Hudson, S. M., Tonelli, A. E., & King, M. W. (2022). [Chitosan based bioadhesives for biomedical applications: A review.](https://doi.org/10.1016/j.carbpol.2022.119100) *Carbohydrate polymers*, *282*, 119100.
34. [â†‘](#cite_ref-34) Merck Manual of Home Health Handbook â€“ 2nd edition, 2003, p. 2097
35. [â†‘](#cite_ref-35) Why Heroin Relapse Often Ends In Death - Lauren F Friedman (Business Insider) | <http://www.businessinsider.com.au/philip-seymour-hoffman-overdose-2014-2>
36. [â†‘](#cite_ref-36) Siegel, S., Hinson, R. E., Krank, M. D., McCully, J. (23 April 1982). ["Heroin "Overdose" Death: Contribution of Drug-Associated Environmental Cues"](https://www.science.org/doi/10.1126/science.7200260). *Science*. **216** (4544): 436â€“437. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1126/science.7200260](//doi.org/10.1126%2Fscience.7200260). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0036-8075](//www.worldcat.org/issn/0036-8075).Â 
37. [â†‘](#cite_ref-37) Darke, S., Zador, D. (December 1996). "Fatal heroin "overdose": a review". *Addiction (Abingdon, England)*. **91** (12): 1765â€“1772. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1046/j.1360-0443.1996.911217652.x](//doi.org/10.1046%2Fj.1360-0443.1996.911217652.x). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [0965-2140](//www.worldcat.org/issn/0965-2140).Â 
38. â†‘ [38.0](#cite_ref-Ershad2020_38-0) [38.1](#cite_ref-Ershad2020_38-1) Ershad, M., Cruz, M. D., Mostafa, A., Mckeever, R., Vearrier, D., Greenberg, M. I. (March 2020). ["Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance"](https://journals.lww.com/10.1097/ADM.0000000000000535). *Journal of Addiction Medicine*. **14** (2): 172â€“174. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1097/ADM.0000000000000535](//doi.org/10.1097%2FADM.0000000000000535). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number")Â [1932-0620](//www.worldcat.org/issn/1932-0620).Â 
39. [â†‘](#cite_ref-39) List of narcotic drugs under international control | <http://www.incb.org/documents/Narcotic-Drugs/Yellow_List/NAR_2011_YellowList_50edition_EN.pdf>
40. [â†‘](#cite_ref-40) WHO Model List of Essential Medicines | <http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1>
41. [â†‘](#cite_ref-41) Vallerand, A. H., Sanoski, C. A. (4 June 2014). *Davisâ€™s Canadian Drug Guide for NursesÂ®*. F.A. Davis. [ISBN](http://en.wikipedia.org/wiki/International_Standard_Book_Number "wikipedia:International Standard Book Number")Â [9780803640863](http://en.wikipedia.org/wiki/Special:BookSources/9780803640863 "wikipedia:Special:BookSources/9780803640863").Â 
42. [â†‘](#cite_ref-42) <http://www.gesetze-im-internet.de/btmg_1981/anlage_iii_61.html>
43. [â†‘](#cite_ref-43) ["éº»è–¬åŠã³å‘ç²¾ç¥è–¬å–ç· æ³•"](https://www.mhlw.go.jp/web/t_doc?dataId=81102000&dataType=0&pageNo=3) [Narcotic and Psychotropic Drugs Control Act] (in Japanese). åšç”ŸåŠ´åƒçœ [Ministry of Health, Labour and Welfare]. Retrieved August 14, 2020.Â 
44. [â†‘](#cite_ref-44) [*ĞŸĞ¾ÑÑ‚Ğ°Ğ½Ğ¾Ğ²Ğ»ĞµĞ½Ğ¸Ğµ ĞŸÑ€Ğ°Ğ²Ğ¸Ñ‚ĞµĞ»ÑŒÑÑ‚Ğ²Ğ° Ğ Ğ¤ Ğ¾Ñ‚ 01.10.2012 N 1002 (Ñ€ĞµĞ´. Ğ¾Ñ‚ 09.08.2019) â€œĞĞ± ÑƒÑ‚Ğ²ĞµÑ€Ğ¶Ğ´ĞµĞ½Ğ¸Ğ¸ Ğ·Ğ½Ğ°Ñ‡Ğ¸Ñ‚ĞµĞ»ÑŒĞ½Ğ¾Ğ³Ğ¾, ĞºÑ€ÑƒĞ¿Ğ½Ğ¾Ğ³Ğ¾ Ğ¸ Ğ¾ÑĞ¾Ğ±Ğ¾ ĞºÑ€ÑƒĞ¿Ğ½Ğ¾Ğ³Ğ¾ Ñ€Ğ°Ğ·Ğ¼ĞµÑ€Ğ¾Ğ² Ğ½Ğ°Ñ€ĞºĞ¾Ñ‚Ğ¸Ñ‡ĞµÑĞºĞ¸Ñ… ÑÑ€ĞµĞ´ÑÑ‚Ğ² Ğ¸ Ğ¿ÑĞ¸Ñ…Ğ¾Ñ‚Ñ€Ğ¾Ğ¿Ğ½Ñ‹Ñ… Ğ²ĞµÑ‰ĞµÑÑ‚Ğ², Ğ° Ñ‚Ğ°ĞºĞ¶Ğµ Ğ·Ğ½Ğ°Ñ‡Ğ¸Ñ‚ĞµĞ»ÑŒĞ½Ğ¾Ğ³Ğ¾, ĞºÑ€ÑƒĞ¿Ğ½Ğ¾Ğ³Ğ¾ Ğ¸ Ğ¾ÑĞ¾Ğ±Ğ¾ ĞºÑ€ÑƒĞ¿Ğ½Ğ¾Ğ³Ğ¾ Ñ€Ğ°Ğ·Ğ¼ĞµÑ€Ğ¾Ğ² Ğ´Ğ»Ñ Ñ€Ğ°ÑÑ‚ĞµĞ½Ğ¸Ğ¹, ÑĞ¾Ğ´ĞµÑ€Ğ¶Ğ°Ñ‰Ğ¸Ñ… Ğ½Ğ°Ñ€ĞºĞ¾Ñ‚Ğ¸Ñ‡ĞµÑĞºĞ¸Ğµ ÑÑ€ĞµĞ´â€¦](https://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=331879&dst=100271&date=03.12.2019)Â 
45. [â†‘](#cite_ref-45) LÃ¤kemedelsverkets fÃ¶reskrifter (LVFS 1997:12) om fÃ¶rteckningar Ã¶ver narkotika, konsoliderad version t.o.m. LVFS 2010:1
46. [â†‘](#cite_ref-46) ["Verordnung des EDI Ã¼ber die Verzeichnisse der BetÃ¤ubungsmittel, psychotropen Stoffe, VorlÃ¤uferstoffe und Hilfschemikalien"](https://www.admin.ch/opc/de/classified-compilation/20101220/index.html) (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.Â 
47. [â†‘](#cite_ref-47) KIRMIZI REÃ‡ETEYE TABÄ° Ä°LAÃ‡LAR | <https://www.titck.gov.tr/storage/Archive/2019/contentFile/K%C4%B1rm%C4%B1z%C4%B1%20Re%C3%A7eteye%20Tabi%20%C4%B0la%C3%A7lar%2005072019_ebcc7e92-6661-4983-870a-fe8983a9c2b7.pdf>
48. [â†‘](#cite_ref-48) Misuse of Drugs Act 1971 c. 38
49. [â†‘](#cite_ref-49) The Misuse of Drugs Regulations 2001 No. 3998